TRNDi010-C

Registration Summary:

A P E C

iPSC HT592C

The cell line is not submitted yet.

(only basic data is shown)

General

iPSC Line
hPSCreg name	TRNDi010-C
Cite as:	TRNDi010-C (RRID:CVCL_XI88)
Alternative name(s)	iPSC HT592C
iPSC line type	Human induced pluripotent stem cell (hiPSC)
Similar iPSC lines	No similar lines found.
Last update	27th March 2019
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	NIH/NCATS-TRND Branch (TRND)
External iPSC Databases
Cellosaurus	CVCL_XI88
Wikidata	Q98133605
General iPSC Information
Publications	Yang S et al. An induced pluripotent stem cell line (TRNDi010-C) from a patient carrying a homozygous p.R401X mutation in the NGLY1 gene. Stem cell research. 2019 Aug;39:101496. Pavlinov I et al. Generation of two gene corrected human isogenic iPSC lines (NCATS-CL6104 and NCATS-CL6105) from a patient line (NCATS-CL6103) carrying a homozygous p.R401X mutation in the NGLY1 gene using CRISPR/Cas9. Stem cell research. 2021 Oct;56:102554. Sasserath T et al. An induced pluripotent stem cell-derived NMJ platform for study of the NGLY1-Congenital Disorder of Deglycosylation. Advanced therapeutics. 2022 Nov;5(11). Dwojak E et al. Six induced pluripotent stem cell lines from fibroblasts of individuals with CLN3-related conditions. Stem cell research. 2024 Dec;81:103563. Zhang Haiwei et al. NGLY1 as an Emerging Critical Modulator for Neurodevelopment and Pathogenesis in the Brain. International Journal of Molecular Sciences. 2025-10-06.

iPSC Derivation

General